Recently, it has been shown that administration of PAI‐1 antagonist or genetic PAI‐1 deficiency suppresses serum phosphate levels in mice apparently by the FGF23 protein degradation by PA and Furin, thereby suppressing serum phosphate levels [14, 17]. The gene discussed is SERPINE1; the disease is hyperinsulinemic hypoglycemia, familial, 4.